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Abstract
Introduction: Kearns-Sayre syndrome is a mitochondrial myopathy that demonstrates chronic
progressive ophthalmoplegia with onset before the age of 20 and pigmentary degeneration of the
retina.
Case presentation: We report the case of an 18-year-old Romanian man with short stature,
external ophthalmoplegia, palpebral ptosis, myopathy, sensorineural hearing impairment, cerebellar
ataxia, cardiac conduction defect, diabetes mellitus, hypoparathyroidism and hyperaldosteronism.
The patient's evolution showed progressive insufficiency of the renal tubule: hyperphosphaturia,
hyperaminoaciduria and, later, glucosuria (de Toni-Debré-Fanconi syndrome), a syndrome, to date,
rarely diagnosed in association with complete Kearns-Sayre syndrome. The final diagnosis was
delayed for several years and was only established when he developed diabetes mellitus. Southern
blot analysis and polymerase chain reaction amplification revealed the presence of a deletion in the
mitochondrial DNA.
Conclusion: Despite the rarity of this syndrome, the diagnosis was easily made due to the
presence of the classic triad: external ophthalmoplegia, pigmentary retinopathy and onset in a
patient younger than 20 years old. In our opinion, a search for Kearns-Sayre syndrome in all
patients with de Toni-Debré-Fanconi syndrome is a valuable medical routine.
Introduction
Mitochondria, which are found in almost all eukaryotic
cells, are the sites of oxidative metabolism and are thus
responsible for generating most of the adenosine-5'-tri-
phosphate (ATP) derived from the breakdown of organic
molecules. The concept of mitochondrial disease was
introduced in 1962, when Luft and co-workers described
a young woman with severe, non-thyroidal hypermetabo-
lism due to loose coupling of oxidation and phosphoryla-
tion in muscle mitochondria [1]. Because many
mitochondrial diseases involve brain and skeletal muscle,
these disorders are also known as mitochondrial enceph-
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alomyopathies. The fact that the respiratory chain is under
dual genetic control makes these disorders particularly
fascinating, because they involve both Mendelian and
mitochondrial genetics. Because mitochondria are ubiq-
uitous, every tissue in the body can be affected by mito-
chondrial deoxyribonucleic acid (mtDNA) mutations,
which is why mitochondrial diseases are often multisys-
temic. mtDNA mutations appear to cause an extensive
array of disorders. As the number and types of mitochon-
drial diseases increase, internists and subspecialists will be
in a pivotal position to recognize and treat these diseases.
Therapy for mitochondrial diseases is inadequate. In the
absence of a clear understanding of basic pathogenetic
mechanisms, treatments have been palliative or have
involved the indiscriminate administration of vitamins,
cofactors, and oxygen-radical scavengers, with the aim of
mitigating, postponing, or circumventing the postulated
damage to the respiratory chain [2,3].
Kearns-Sayre syndrome (KSS) is a related mitochondrial
myopathy that demonstrates the following: chronic pro-
gressive ophthalmoplegia (CPEO), onset before the age of
20 and pigmentary degeneration of the retina; abnormal
accumulation of colored (pigmented) material on the
nerve-rich membrane lining the eyes (atypical retinitis
pigmentosa) leads to chronic inflammation, progressive
degeneration, and wearing away of certain eye structures
[4]. In addition, KSS may include cardiac conduction
defects, cerebellar ataxia, and raised cerebrospinal fluid
(CSF) protein levels (> 100 mg/dl). KSS may affect many
organ systems, for example, diabetes, growth retardation
and/or short stature, hypoparathyroidism, myopathy,
bilateral sensorineural hearing loss, cataracts, dementia,
dystonia, and proximal renal tubular acidosis [5]. Other
findings may include muscle weakness, short stature,
hearing loss, and/or the loss of the ability to coordinate
voluntary movements (ataxia) due to problems affecting
part of the brain (cerebellum). Mitochondrial encephalo-
myopathies are disorders where a defect in genetic mate-
rial arises from a part of the cell structure that releases
energy (mitochondria), causing the brain and muscles to
function improperly (encephalomyopathies). In these
disorders, abnormally high numbers of defective mito-
chondria are present. In approximately 80% of cases of
KSS, tests will reveal missing genetic material (deletions)
involving the unique mtDNA [6].
The possibility of mitochondrial dysfunction needs to be
taken into account by every medical subspecialty [7]. KSS
occurs secondary to deletions in mtDNA that cause a par-
ticular phenotype (Online Mendelian Inheritance in Man
(OMIM) 53000) [5]. Despite the rarity of this syndrome,
the diagnosis could be easily made in the presence of the
classic triad: external ophthalmoplegia, pigmentary retin-
opathy and onset in a patient younger than 20 years old
[8].
Case presentation
We report the case of an 18-year-old Romanian man with
short stature, external ophthalmoplegia, palpebral ptosis,
myopathy, sensorineural hearing impairment, cerebellar
ataxia, cardiac conduction defect, diabetes mellitus,
hypoparathyroidism, and hyperaldosteronism. The
patient presented initially with endocrinological abnor-
malities such as failure to thrive, hyperaldosteronism and
hypoparathyroidism. Despite his palpebral ptosis and
progressive encephalomyopathy with cerebellar ataxia,
the initial diagnosis was not KSS. Subsequently, he devel-
oped progressive external ophthalmoplegia, retinopathy,
heart block, and diabetes mellitus. The diagnosis was
delayed for many years.
The patient's initial infant development was normal (Fig-
ure 1). The first physical sign noted by his parents was
growth retardation, but initially this was not related to any
disease or disorder. During the first 3 to 4 years of his
childhood, the most striking clinical sign was the failure
to thrive. The child was seen by several doctors, and based
on clinical examination and laboratory tests, an initial
diagnosis was made. In a different hospital, the patient
was diagnosed with renal tubular dysfunction with
decreased urine-concentrating ability, and excessive excre-
tion of potassium and magnesium. The renal dysfunction
was thought to have resulted from Bartter syndrome, due
to the presence of hyperaldosteronism and hypokalemia.
The renal phenotype characterized by hypokalemia,
hypomagnesemia, hyperreninemia, hyperaldosteronism
and nephrocalcinosis, resembling Bartter syndrome, was
Patient with Kearns-Sayre syndrome at 3 months of age (nor- mal appearance) Figure 1
Patient with Kearns-Sayre syndrome at 3 months of 
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diagnosed when the boy was 4 years old. Replacement of
substances lost in urine was started (potassium, vitamin
D, calcium), when carpopedal spasms occurred, therefore,
spironolactone was added. Despite the presence of meta-
bolic acidosis, the Bartter syndrome diagnosis was main-
tained, and oral bicarbonate was added. In addition,
drooping of the upper eyelid (ptosis) bilaterally was also
noted during his childhood (Figure 2A), but was very mild
and was probably ignored. Other muscles involved in
coordinating eye movements were affected next, growing
progressively weaker and resulting in paralysis of eye
movements (chronic progressive external ophthalmople-
gia) at 9 years of age. Muscle weakness extended to other
portions of his lower legs, then his face, throat (pharynx),
neck, and shoulders. Muscle weakness affected talking
and swallowing, as the disease progressed (Figure 2B). His
upper arms and legs were affected, resulting in progressive
impairment of coordinated movement and a very difficult
gait. The patient also developed visual difficulties as a tod-
dler, due to the abnormal accumulation of colored (pig-
mented) material on the delicate membrane that lines the
eyes (atypical retinitis pigmentosa) and progressive
degeneration of certain portions of the eye (pigmentary
degeneration of the retina). Additional physical character-
istics and symptoms in this patient included: develop-
mental delay; short stature (Figure 3); diminished muscle
tone; hearing loss; mental retardation; progressive mem-
ory loss and deterioration of intellectual abilities; and
multiple endocrine dysfunction. The combination hypo/
normotension, high serum renin and high serum aldos-
terone suggested secondary hyperaldosteronism. Renal
tubular wasting of potassium and magnesium was docu-
mented. Also, low immunoreactive parathyroid hormone
levels in the presence of hypocalcemia confirmed a diag-
nosis of hypoparathyroidism. The very first of these disor-
ders occurring in association with KSS was
hypoparathyroidism with hypocalcemia and hyperaldos-
teronism. The patient's evolution showed progressive
insufficiency of the renal tubule: hyperphosphaturia,
hyperaminoaciduria and, later, also glucosuria (de Toni-
Debré-Fanconi syndrome), a syndrome, to date, rarely
diagnosed in association with complete Kearns-Sayre syn-
drome.
The final diagnosis was established in our department,
when our patient developed diabetes mellitus and was
admitted with severe keto-acidosis, based on clinical man-
ifestations (since mitochondrial disorders affect respira-
tory chain function, the disorders may be expected to have
the greatest effect on cells or organ systems with the high-
est energy requirements, for example, the brain, skeletal
and cardiac muscle, sensory organs, kidneys), muscular
biopsy and additional laboratory findings and tests: low
(A) The patient with Kearns-Sayre syndrome at 7 years of  age, when the eyelid ptosis was documented for the first  time Figure 2
(A) The patient with Kearns-Sayre syndrome at 7 
years of age, when the eyelid ptosis was documented 
for the first time. (B) The patient with Kearns-Sayre syn-
drome at 12 years of age when the diagnosis of diabetes mel-
litus was established. Note the progression of the palpebral 
ptosis.
The patient with Kearns-Sayre syndrome (right) with an age- matched boy (left) Figure 3
The patient with Kearns-Sayre syndrome (right) with 
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magnesium and parathyroid hormone, increased lactic
acid, creatine phosphokinase and protein in CSF, abnor-
mal electroretinography and visual-evoked potential test-
ing. Southern blot analysis and polymerase chain reaction
(PCR) amplification revealed the presence of a deletion in
the mtDNA.
Investigations revealed lactic acidosis, electrolytic imbal-
ance and urinary loss of glucose and electrolytes second-
ary to proximal renal tubulopathy consistent with
Fanconi syndrome.
The diagnosis of Kearns-Sayre Syndrome was established
based on the three primary characteristics: CPEO, atypical
retinitis pigmentosa, and cardiomyopathy-cardiac con-
duction defects. Soon after the diagnosis of diabetes mel-
litus was established, we diagnosed the cardiomyopathy;
the presence of a complete right bundle branch block with
left anterior hemiblock and Mobitz type 2 second degree
atrioventricular (AV) block (Figure 4).
Microscopic examination of muscle biopsy tissue samples
revealed the presence of the ragged-red fibers.
The brain computed tomography scan was used to iden-
tify abnormal lesions affecting certain areas of the brain -
this procedure revealed signs of generalized cerebral and
cerebellar atrophy and areas of hypointensity in basal gan-
glia and the brain magnetic resonance imaging showed a
combination of high-signal foci in subcortical cerebral
white matter and in the brain stem, globus pallidus and
thalamus. Treatment of heart problems required a pace-
maker for AV block. He improved soon after the implan-
tation of a permanent endocardial pacemaker.
Neurosensorial hearing loss assessed by audiometry (Fig-
ure 5) necessitated bilateral hearing aids.
Diabetes mellitus was treated with insulin, using a combi-
nation of rapid-acting analogues and lente insulin and
hypoparathyroidism with 1,25-dihydroxycholecalciferol
and ketosteril (amino acids plus calcium). Coenzyme
Q10, riboflavin, and vitamins C and K were added to his
treatment. At 15 years of age, the patient started to
develop progressive kidney failure, and a treatment with
erythropoietin was started as well.
Discussion
The patient presented initially with endocrinological
abnormalities: failure to thrive, hyperaldosteronism and
hypoparathyroidism. Despite his palpebral ptosis and
progressive encephalomyopathy with cerebellar ataxia,
the initial diagnosis was delayed for many years, probably
because KSS is mainly recognized as a neurologic disorder
with variable encephalomyopathic symptoms.
During the first three to four years of his childhood, the
most striking clinical sign was the failure to thrive. Hypoc-
alcemic tetany occurred at the age of four, with paresthesia
and carpopedal spasms. At the same time, a renal pheno-
type characterized by hypokalemia, hypomagnesemia,
hyperreninemia, and hyperaldosteronism was diagnosed,
but the real diagnosis was not recognized by the doctors
initially involved in the child's care.
He was referred to our hospital by his general practitioner,
many years after the onset of this unusual combination of
signs and symptoms, when he developed diabetes melli-
tus, at the age of 12. Despite the myopathic presentation,
in association with several non-neurologic signs, the diag-
nosis of KSS was not suggested by any of the physicians.
Later, after the real diagnosis had been established in our
department, we were alert for other clinical and therapeu-
Electrocardiogram - cardiac conduction defect Figure 4
Electrocardiogram - cardiac conduction defect.Journal of Medical Case Reports 2009, 3:101 http://www.jmedicalcasereports.com/content/3/1/101
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tic implications, such as heart involvement, diabetes man-
agement and kidney failure. Managing diabetes in
patients with end-stage renal disease is often problematic,
because renal failure interferes with the metabolism of
glucose and insulin with wide fluctuations in the daily
blood glucose profile. For this reason, our option was to
choose a flexible insulin therapy for our patient, using a
combination of rapid-acting and long-acting insulin ana-
logues, based on the evidence that using insulin ana-
logues in patients with diabetes and renal failure is safe
and helps to avoid large fluctuations in blood glucose lev-
els [9]. KSS can involve many organs and systems. Clini-
cians must maintain constant and comprehensive
surveillance, and be especially alert for signs and symp-
toms of diabetes mellitus, heart block and for hypopar-
athyroidism, because the cardiovascular effects of
hypocalcemia, bradydysrhythmias or prolongation of the
QT interval could be life-threatening. Treating our patient
was very challenging because his evolution related to his
parathyroidism and hypocalcemia, and he had repeated
tetanic symptoms with generalized convulsions and stiff-
ness.
Cases with hypoparathyroidism have been considered to
constitute a distinct subgroup in the medical literature.
Dewhurst  et al. [10] described a patient with KSS and
hypocalcemia without basal ganglia calcifications and
they assumed that this was due to the early treatment of
hypoparathyroidism. Later, cases of KSS with hypoparath-
yroidism were considered separately to assess if they con-
stituted a distinct subgroup with multiple endocrine
dysfunction [9]. Concerning the hypoparathyroidism,
this was associated with other endocrine and metabolic
dysfunctions, but the authors considered that this was
likely to be due to increased recognition rather than
increased prevalence, because bone or tooth abnormali-
ties and calcification of the basal ganglia were found in
those with and without hypoparathyroidism [11]. Four
years later, a group of Japanese authors reported a patient
with KSS in whom they described the presence of HLA-
A24 and CW3 antigen that could be responsible for the
association of insulin-dependent diabetes mellitus
(IDDM) and hypoparathyroidism, similar to Japanese
patients with polyglandular autoimmune syndrome, and
suggesting that a genetic linkage, as well as mitochondrial
dysfunction, may be responsible for the association of the
two disease states [12].
Considering the association of KSS with hypoparathy-
roidism, our patient presented with hypocalcemia at 4
years of age and the hypoparathyroidism was proven by
reduced serum concentrations of parathyroid hormone
(PTH) and hyperphosphatemia. No evidence of dietary,
malabsorbent, metabolic vitamin D disorders or autoim-
mune mechanisms, which have been assumed to cause
hypoparathyroidism in KSS, were noted in our patient.
Severe hypomagnesemia, known to suppress PTH secre-
tion, was also observed in this patient.
Searching the PubMed database, we found only eight arti-
cles describing the association between the presence of de
Toni-Debré-Fanconi syndrome and Kearns Sayre syn-
drome [13-20]. This highly unusual clinical presentation
emphasizes the need for systemic investigation of patients
with Fanconi syndrome and further underlines the impor-
tance of mtDNA analysis in patients with unexpected
associations of affected tissues [13]. Mitochondrial cytop-
athy is a multisystem disease that requires different phar-
macological and specialist approaches. Relationships
between retinal and kidney disorders advocate a search for
de Toni-Debré-Fanconi syndrome in all patients with
Audiogram Figure 5
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Kearns-Sayre syndrome and also the use of quantitative
and chromatographic methods for the assessment of
amino acids, phosphates and sugars in urine [14,15].
Conclusion
Despite the rarity of this syndrome, diagnosis could easily
be made in the presence of the classic triad: external oph-
thalmoplegia, pigmentary retinopathy and onset in a
patient younger than 20 years of age, if this clinical pres-
entation is recognized and identified as a mitochondrial
disorder.
We consider that practitioners should be aware of the
presence of mitochondrial myopathies, and the broad
spectrum of their clinical presentations. Also, the diagno-
sis of de Toni-Debré-Fanconi syndrome in a patient
should be followed by extensive research into the possible
presence of an associated mitochondrial myopathy.
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